Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Lancet Haematol
; 6(5): e239-e253, 2019 May.
Article
in En
| MEDLINE
| ID: mdl-30981783
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Wiskott-Aldrich Syndrome
/
Hematopoietic Stem Cells
/
Genetic Therapy
/
Lentivirus
/
Genetic Vectors
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Country/Region as subject:
Europa
Language:
En
Journal:
Lancet Haematol
Year:
2019
Document type:
Article